J&J | JNJ - الربح قبل الضريبة





الربح قبل الضريبة تغيير تاريخ
AbbVie USD 5.57B 2.9B 2026-03
Abbott USD 2.39B 27M 2026-03
Amgen USD 1.51B 2.41B 2025-12
AstraZeneca USD 3.91B 1.28B 2026-03
Baxter International USD -756M 877M 2025-12
Bayer EUR -3.37B 2.21B 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Biogen USD 377.7M 433.7M 2026-03
Boston Scientific USD 700M 238M 2025-12
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
CONMED USD 29.25M 24.98M 2025-12
Cooper Companies USD 192.2M 75.4M 2025-12
Dexcom USD 340.7M 40.7M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Eli Lilly USD 8.27B 1.03B 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
Globus Medical USD 169.23M 25.24M 2025-12
Insulet USD 113M 27.2M 2026-03
Integra LifeSciences USD -2.41M 6.72M 2026-03
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Medtronic USD 2.45B 1.04B 2026-03
Merck USD 3.42B 3.32B 2025-12
Merit Medical Systems USD 51.06M 22.12M 2025-12
Novartis USD 3.84B 802M 2026-03
Pfizer USD 5.18B 6.82B 2026-03
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD 4.68M 29.82M 2025-12
Teva Pharmaceutical Industries USD 753M 662M 2026-03
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03
Zimmer Biomet Holdings USD 98M 320.7M 2025-12
Zoetis USD 761M 126M 2025-12